Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
about
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.MMP-1 expression has an independent prognostic value in breast cancer.A reconstructed metastasis model to recapitulate the metastatic spread in vitro.Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancerPlasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.Overexpression of MMP-3 and uPA with Diminished PAI-1 Related to Metastasis in Ductal Breast Cancer Patients Attending a Public Hospital in Mexico CitySpecific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery.Diagnostic and prognostic relevance of MMP-11 expression in the stromal fibroblast-like cells adjacent to invasive ductal carcinoma of the breast.Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study.Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node.Tumour-related factors and prognosis in breast cancer detected by screening.
P2860
Q30978083-CD845806-121F-485C-90AD-3317EA5C641BQ33880656-85C13775-790F-4822-8D6F-9D7DDF72078DQ33991012-2A3C65F3-C5A0-4F5C-BDE9-AF906421DF68Q34115770-B6DB9E4F-FF24-4F15-A6D4-7582918414B2Q35586223-53654BA6-A09C-4E44-AB8A-0FFF331655B7Q36631494-4131500C-E04C-4B71-BE4C-5705805EBC09Q37386814-E94C1BFE-3A50-40E0-8ADD-C8127CE446B4Q37448568-393867A3-4305-4632-AC4A-F078EA7C8F46Q38856698-DB7A384E-AD1D-43E5-9EB3-68488A0AF912Q42077942-B11A321D-B506-4AD5-AAEA-64BD54640DD9Q44891886-FA5F4B98-707B-4258-86CB-345411E65A29Q48277694-9792705A-73F3-4322-BF30-14904963EAADQ51155840-4A05529B-5293-49C8-9D67-DF7A70F530A5Q54549875-71580BE3-4A86-4B83-AF77-EF5C644498BBQ54551265-A91391FF-FA26-4D86-A171-D3D189ABADFB
P2860
Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Comparative study of the expre ...... lymph nodes of breast cancer.
@en
Comparative study of the expre ...... lymph nodes of breast cancer.
@nl
type
label
Comparative study of the expre ...... lymph nodes of breast cancer.
@en
Comparative study of the expre ...... lymph nodes of breast cancer.
@nl
prefLabel
Comparative study of the expre ...... lymph nodes of breast cancer.
@en
Comparative study of the expre ...... lymph nodes of breast cancer.
@nl
P2093
P2860
P1476
Comparative study of the expre ...... lymph nodes of breast cancer.
@en
P2093
Francisco José Vizoso
José Manuel Del Casar
Luis Ovidio González
María Fernanda García
María Medina
Nana Berdize
Salomé González-Reyes
Sara Junquera
P2860
P304
P356
10.1111/J.1365-2613.2010.00709.X
P577
2010-04-20T00:00:00Z